Back to Search Start Over

A mutational hotspot in AMOTL1 defines a new syndrome of orofacial clefting, cardiac anomalies, and tall stature.

Authors :
Strong A
Rao S
von Hardenberg S
Li D
Cox LL
Lee PC
Zhang LQ
Awotoye W
Diamond T
Gold J
Gooch C
Gowans LJJ
Hakonarson H
Hing A
Loomes K
Martin N
Marazita ML
Mononen T
Piccoli D
Pfundt R
Raskin S
Scherer SW
Sobriera N
Vaccaro C
Wang X
Watson D
Weksberg R
Bhoj E
Murray JC
Lidral AC
Butali A
Buckley MF
Roscioli T
Koolen DA
Seaver LH
Prows CA
Stottmann RW
Cox TC
Source :
American journal of medical genetics. Part A [Am J Med Genet A] 2023 May; Vol. 191 (5), pp. 1227-1239. Date of Electronic Publication: 2023 Feb 07.
Publication Year :
2023

Abstract

AMOTL1 encodes angiomotin-like protein 1, an actin-binding protein that regulates cell polarity, adhesion, and migration. The role of AMOTL1 in human disease is equivocal. We report a large cohort of individuals harboring heterozygous AMOTL1 variants and define a core phenotype of orofacial clefting, congenital heart disease, tall stature, auricular anomalies, and gastrointestinal manifestations in individuals with variants in AMOTL1 affecting amino acids 157-161, a functionally undefined but highly conserved region. Three individuals with AMOTL1 variants outside this region are also described who had variable presentations with orofacial clefting and multi-organ disease. Our case cohort suggests that heterozygous missense variants in AMOTL1, most commonly affecting amino acid residues 157-161, define a new orofacial clefting syndrome, and indicates an important functional role for this undefined region.<br /> (© 2023 Wiley Periodicals LLC.)

Details

Language :
English
ISSN :
1552-4833
Volume :
191
Issue :
5
Database :
MEDLINE
Journal :
American journal of medical genetics. Part A
Publication Type :
Academic Journal
Accession number :
36751037
Full Text :
https://doi.org/10.1002/ajmg.a.63130